Foghorn Therapeutics : May 2023 Foghorn Investor Presentation
CORPORATE OVERVIEW Leveraging unique insights into the chromatin regulatory system to pioneer a new class of precision therapies in oncology and... | May 8, 2023
United States Gene Traffic Control Platform Foghorn Therapeutics Inc Stock Exchange Press Release Ncology Fhtx Us3441741077
Source: marketscreener.com